Key result
Statins may prevent atrial fibrillation through pleiotropic and anti-inflammatory mechanisms independent of cholesterol reduction, though further large-scale randomized trials are needed.
Why the study?
Do statins prevent atrial fibrillation in patients at risk or with existing AF?
Do statins prevent atrial fibrillation in patients at risk or with existing AF?
Statins may have beneficial pleiotropic effects in preventing atrial fibrillation in various clinical scenarios, independent of their lipid-lowering properties.
Answers are grounded in this paper and cite their sources.
Does not support statin use for AF prevention; leaves open confirmation via large RCTs.
Pleiotropic effects of statins in atrial fibrillation patients: the evidence Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer EllahhamInstitute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab EmiratesAbstract: Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice. The understanding of the pathophysiology of AF has changed during the last several decades, and a significant role of inflammation and of the renin–angiotensin–aldosterone system has been postulated both experimentally and clinically. There is emerging evidence of an association between inflammation and AF, and mounting evidence links increased C-reactive protein levels not only to already existing AF but also to the risk of developing future AF. The beneficial effects of statins on AF have been reported in several studies. Several randomized clinical and large observational studies have shown similar result that show the beneficial effect of statins in AF. In clinical studies, statins were considered effective in preventing AF after electrical cardioversion, post-ablation, and after permanent pacemaker and implantable cardioverter defibrillator insertion. The antiarrhythmic mechanisms of statins regarding AF prevention in patients with heart failure are still not clear. Perioperative statin use has been associated with favorable postoperative outcome in both cardiovascular and noncardiovascular conditions. Despite a growing body of evidence that drugs with anti-inflammatory properties such as statins may prevent AF, the observed positive effects of statins on the burden of AF appeared to be independent of their cholesterol-reducing properties. However, further data from large-scale randomized trials are clearly needed.
No takes yet. Share an insight, caveat, or question.
Hadi (2009) conducted a review in Atrial fibrillation. Statins was evaluated. Statins may prevent atrial fibrillation through pleiotropic and anti-inflammatory mechanisms independent of cholesterol reduction, though further large-scale randomized trials are needed.
Synapse has enriched 10 related papers. Consider them for comparative context: